Epidemiology of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease in Taiwan

Overview

Journal J Epidemiol Glob Health

Publisher Springer

Date 2024 Feb 14

PMID 38353916

Authors

Kuang-Ming Liao

Chuan-Wei Shen

Kai-Lin Chiu

Chun-Hui Lu

Chih-Wun Fang

Chung-Yu Chen

Affiliations

Soon will be listed here.

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic condition characterized by progressive, partially reversible airflow obstruction. Osteoporosis represents a significant comorbidity in individuals with COPD. However, the incidence and prevalence of osteoporosis among the COPD population remain unclear in Taiwan. Therefore, our objective is to investigate the incidence and prevalence of osteoporosis in patients with COPD.

Methods: In this cross-sectional study, we enrolled a COPD population retrieved from the Taiwan National Health Insurance Research Database (NHIRD) spanning the years 2003 to 2016. Osteoporosis patients were identified using diagnosis codes. The study included newly diagnosed COPD patients from 2003 to 2016. The case group comprised patients who developed osteoporosis or osteoporotic fractures after their COPD diagnosis. We calculated the prevalence and incidence of osteoporosis in individuals with COPD and conducted trend tests.

Results: A total of 1,297,579 COPD patients were identified during the period from 2003 to 2016, with 275,233 of them in the osteoporosis group. The average prevalence of osteoporosis among individuals with COPD was 21.21% from 2003 to 2016 in Taiwan. The number of osteoporosis cases increased from 6,727 in 2003 to 24,184 in 2016. The prevalence of osteoporosis among COPD patients increased from 3.62% in 2003 to 18.72% in 2016. The number of osteoporosis cases among individuals with COPD continued to rise over the years, reaching its highest point in 2016 with 24,184 new cases. The incidence of osteoporosis fluctuated during the study period but generally remained around 3,000 cases per 100,000 person-years. Notably, there was a significant upward trend in incidence from 2003 to 2006, after which the trend stabilized and remained relatively constant.

Conclusions: Our study highlights an increase in both the prevalence and incidence of osteoporosis in individuals with COPD. Given the significant medical, economic, and social implications associated with osteoporosis, a comprehensive and robust assessment of its healthcare burden can offer valuable insights for healthcare system planning and policymaking.

References

Tashkin D, Strange C . Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. Int J Chron Obstruct Pulmon Dis. 2018; 13:2587-2601. PMC: 6118265. DOI: 10.2147/COPD.S172240. View

Devine J . Chronic obstructive pulmonary disease: an overview. Am Health Drug Benefits. 2014; 1(7):34-42. PMC: 4106574. View

Fraser L, Adachi J . Glucocorticoid-induced osteoporosis: treatment update and review. Ther Adv Musculoskelet Dis. 2012; 1(2):71-85. PMC: 3383483. DOI: 10.1177/1759720X09343729. View

Compston J . Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018; 61(1):7-16. PMC: 5997116. DOI: 10.1007/s12020-018-1588-2. View

Romme E, Smeenk F, Rutten E, Wouters E . Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2013; 7(4):397-410. DOI: 10.1586/17476348.2013.814402. View

Parker C, Voduc N, Aaron S, WEBB K, ODonnell D . Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005; 26(3):420-8. DOI: 10.1183/09031936.05.00136304. View

Singh D, Agusti A, Anzueto A, Barnes P, Bourbeau J, Celli B . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019; 53(5). DOI: 10.1183/13993003.00164-2019. View

10.

Inoue D, Watanabe R, Okazaki R . COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016; 11:637-48. PMC: 4820217. DOI: 10.2147/COPD.S79638. View

11.

Lin C, Chen Y, Chen Y, Liang C, Lin M, Chen W . Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis. 2015; 10:1493-500. PMC: 4524376. DOI: 10.2147/COPD.S85432. View

12.

Lin Y, Pan W . Bone mineral density in adults in Taiwan: results of the Nutrition and Health Survey in Taiwan 2005-2008 (NAHSIT 2005-2008). Asia Pac J Clin Nutr. 2011; 20(2):283-91. View

13.

Lin Y, Huang C . Aging in Taiwan: Building a Society for Active Aging and Aging in Place. Gerontologist. 2015; 56(2):176-83. DOI: 10.1093/geront/gnv107. View

14.

Yu S, Chou C, Lai H, Chen Y, Chiu C, Kuo M . Adherence to anti-osteoporotic regimens in a Southern Taiwanese population treated according to guidelines: a hospital-based study. Int J Rheum Dis. 2012; 15(3):297-305. DOI: 10.1111/j.1756-185X.2012.01719.x. View

15.

Ho Chan W . Taiwan's healthcare report 2010. EPMA J. 2012; 1(4):563-85. PMC: 3405348. DOI: 10.1007/s13167-010-0056-8. View

16.

Chen F, Huang T, Fu T, Sun C, Chao A, Tsai T . Secular trends in incidence of osteoporosis in Taiwan: A nationwide population-based study. Biomed J. 2018; 41(5):314-320. PMC: 6306299. DOI: 10.1016/j.bj.2018.08.001. View

17.

Ferguson G, Calverley P, Anderson J, Jenkins C, Jones P, Willits L . Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest. 2009; 136(6):1456-1465. DOI: 10.1378/chest.08-3016. View

18.

Li L, Brennan K, Gaughan J, Ciccolella D, Kuzma A, Criner G . African Americans and men with severe COPD have a high prevalence of osteoporosis. COPD. 2008; 5(5):291-7. DOI: 10.1080/15412550802363329. View

19.

Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K . Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2014; 33(4):392-400. DOI: 10.1007/s00774-014-0605-7. View

20.

Hattiholi J, Gaude G . Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India. Lung India. 2014; 31(3):221-7. PMC: 4129592. DOI: 10.4103/0970-2113.135759. View

21.

Graat-Verboom L, Smeenk F, van den Borne B, Spruit M, Jansen F, van Enschot J . Progression of osteoporosis in patients with COPD: a 3-year follow up study. Respir Med. 2012; 106(6):861-70. DOI: 10.1016/j.rmed.2011.12.020. View

22.

Silva D, Coelho A, Dumke A, Valentini J, de Nunes J, Stefani C . Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care. 2011; 56(7):961-8. DOI: 10.4187/respcare.01056. View